Poor outcome of patients with COVID-19 after CAR T-cell therapy for B-cell malignancies: results of a multicenter study on behalf of the European Society for Blood and Marrow Transplantation (EBMT) Infectious Diseases Working Party and the European Hematology Association (EHA) Lymphoma Group

  1. Spanjaart, A.M.
  2. Ljungman, P.
  3. de La Camara, R.
  4. Tridello, G.
  5. Ortiz-Maldonado, V.
  6. Urbano-Ispizua, A.
  7. Barba, P.
  8. Kwon, M.
  9. Caballero, D.
  10. Sesques, P.
  11. Bachy, E.
  12. Di Blasi, R.
  13. Thieblemont, C.
  14. Calkoen, F.
  15. Mutsaers, P.
  16. Maertens, J.
  17. Giannoni, L.
  18. Nicholson, E.
  19. Collin, M.
  20. Vaz, C.P.
  21. Metafuni, E.
  22. Martinez-Lopez, J.
  23. Dignan, F.L.
  24. Ribera, J.-M.
  25. Nagler, A.
  26. Folber, F.
  27. Sanderson, R.
  28. Bloor, A.
  29. Ciceri, F.
  30. Knelange, N.
  31. Ayuk, F.
  32. Kroger, N.
  33. Kersten, M.J.
  34. Mielke, S.
  35. Show all authors +
Journal:
Leukemia

ISSN: 1476-5551,  0887-6924

Year of publication: 2021

Volume: 35

Issue: 12

Pages: 3585-3588

Type: Article

DOI: 10.1038/S41375-021-01466-0 GOOGLE SCHOLAR lock_openOpen access editor
Data source: Scopus